Phoenix Wealth Advisors’s Evogene EVGN Stock Holding History

Phoenix Wealth Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-600	Closed	-$16K	–	195
2021 Q3	$16K	Hold	600	–	–	0.01%	276
2021 Q2	$20K	Hold	600	–	–	0.01%	256
2021 Q1	$29K	Hold	600	–	–	0.02%	228
2020 Q4	$29K	Buy	+600	New	+$21.2K	0.02%	227

Other funds holding EVGN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Phoenix Wealth Advisors's EVGN Position: Q4 2021 in Review

Phoenix Wealth Advisors sold out of Evogene (EVGN) in Q4 2021, closing a stake of 600 shares — an estimated $16K sold.

Phoenix Wealth Advisors first reported a position in EVGN in Q4 2020 and held it in 4 quarters. The position peaked at $29K in Q1 2021. 42 funds tracked by Wall St. Rank hold EVGN as of Q4 2021.

Phoenix Wealth Advisors reported no remaining Evogene position as of Q4 2021 after selling out during the quarter.
Phoenix Wealth Advisors sold 600 Evogene shares in Q4 2021, an estimated $16K.
Phoenix Wealth Advisors first reported a position in Evogene in Q4 2020 and held it in 4 quarters.
Phoenix Wealth Advisors's Evogene position peaked at $29K in Q1 2021.
42 funds tracked by Wall St. Rank held Evogene as of Q4 2021.

Based on Phoenix Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.